Psoriasis may be underdiagnosed in UK primary care settings, according to research led by researchers from The University of Manchester. The findings, published in the British Journal of General Practice, show that missed ...
Aug 31, 2022
0
3
There is unmet need for the treatment of generalized pustular psoriasis (GPP) flares, according to a study published online Aug. 10 in JAMA Dermatology.
Aug 15, 2022
0
7
Adults who received image-guided corticosteroid injections for musculoskeletal pain between April 2020 and February 2021 had a lower incidence of symptomatic COVID-19 than the general population in Massachusetts, according ...
Jul 14, 2022
0
0
The combination of corticosteroid injections and exercise therapy helps reduce symptoms of long-standing Achilles tendinopathy, according to a study published online July 11 in JAMA Network Open.
Jul 13, 2022
0
3
When taking medicine during an asthma attack, patients with the most severe form of asthma produce in their airways special substances that block the treatment from working, according to a study where Rutgers scientists collaborated ...
May 30, 2022
0
136
The Best Emollients for Eczema trial has found that no one type of moisturiser is better than another. This study, the first in the world to directly compare different types of moisturisers, highlights the importance of ...
May 24, 2022
0
1
New research published in JAMA recommends daily steroid doses for children with Duchenne muscular dystrophy (DMD), marking a significant change in how the disease is treated. University of Rochester Medical Center (URMC) ...
May 4, 2022
0
9
People with sickle cell disease (SCD) who were recently prescribed a corticosteroid—a medicine frequently used to treat asthma or inflammation—were found to be significantly more likely to be hospitalized for a severe ...
Apr 26, 2022
0
54
The messenger substance interleukin-3 produced by the body was previously considered to be pro-inflammatory in bronchial asthma. A research team from Universitätsklinikum Erlangen has now shown for the first time that the ...
Apr 21, 2022
0
60
The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.
Jan 19, 2022
0
4
